DV
Dividend Vision

INO — Inovio Pharmaceuticals Inc

Inovio Pharmaceuticals Inc (INO)

Total return is -99.8% over the past 27.7 years, 1061.0 points behind SPY at 961.2%. Its deepest 1-year drawdown was 77.0%.

INO is an individual equity stock in the pharmaceutical sector that trades with monthly distribution frequency. As a single-stock holding rather than a diversified fund, it offers direct exposure to Inovio Pharmaceuticals' business performance without the diversification typical of ETFs. This structure appeals primarily to investors seeking concentrated exposure to a specific biotech company, though it carries higher risk than traditional dividend ETFs due to lack of diversification and the company's current lack of dividend payments.

INO key facts

Asset type
Stock
Asset class
Equity
Inception date
12/08/1998
Distribution frequency
Monthly
Last close
$1.09
Market cap
$89,677,832
Average volume
12185000.0
Ex-dividend date
09/28/2017
Payment date
10/16/2017
Beta
1.485
Payout ratio
0.0
Forward P/E
16.5837
EPS
$-1.54